Enanta Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.67-1.65-2.04-2.17
Price/Sales ratio
2.352.441.250.77
Earnings per Share (EPS)
$-4.99$-5.05$-4.10$-3.86

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
8.5423.2450.3824.1325.36-25.23-14.50-8.77-1.75-1.88-6.68-6.68
Price/Sales ratio
4.195.708.678.405.737.4511.8012.402.953.249.825.73
Price/Book Value ratio
2.851.862.954.412.542.002.863.321.081.702.682.54
Price/Cash Flow ratio
8.8014.0616.9459.4416.47128.78-16.37-12.60-2.27-2.78-7.52128.78
Price/Free Cash Flow ratio
9.0716.2117.7966.1917.82161.76-16.19-12.29-2.08-2.26-7.19161.76
Price/Earnings Growth ratio
0.06-0.31-2.730.08-0.790.14-0.12-0.17-0.220.130.13-0.79
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%100%100%96.54%100%100%23.72%100%
Operating Profit Margin
77.16%34.94%23.94%42.74%17.90%-33.99%-112.87%-143.73%-173.23%-179.92%-150.36%-33.99%
Pretax Profit Margin
77.98%36.88%26.20%45.06%22.20%-28.59%-110.82%-141.81%-165.38%-174.15%-147.49%-28.59%
Net Profit Margin
49.1%24.54%17.22%34.82%22.60%-29.53%-81.37%-141.31%-168.95%-171.57%-146.93%-29.53%
Effective Tax Rate
37.03%33.45%34.27%22.72%-1.81%-3.28%26.56%0.35%-2.15%1.47%0.38%-1.81%
Return on Assets
32.10%7.70%5.42%17.37%9.46%-7.43%-18.00%-32.43%-28.94%-30.80%-34.70%-7.43%
Return On Equity
33.44%8.02%5.87%18.27%10.02%-7.93%-19.77%-37.89%-61.74%-90.08%-36.58%-7.93%
Return on Capital Employed
51.87%11.28%8.05%22.18%7.86%-9.01%-27.21%-35.83%-34.34%-38.13%-38.03%-9.01%
Liquidity Ratios
Current Ratio
25.4529.4211.3323.7317.7718.08N/AN/AN/AN/A12.3318.08
Quick Ratio
25.4529.4211.3323.7317.7718.089.8410.456.735.2111.5518.08
Cash ratio
3.242.103.133.982.263.601.581.471.350.641.833.60
Days of Sales Outstanding
35.6653.0937.68118.7191.2770.01228.72207.73182.5735.86228.0291.27
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A207.73N/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A736.62N/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-528.89N/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.010.000.00N/A0.000.130.13
Debt Equity Ratio
N/AN/AN/AN/AN/A0.010.010.00N/A0.010.150.15
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.00N/AN/AN/AN/A0.060.00
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.010.010.00N/A0.010.070.07
Interest Coverage Ratio
15.51K685.35615.35N/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A1.23-16.65-29.32N/A-51.68-4.221.23
Company Equity Multiplier
1.041.041.081.051.051.061.091.162.132.921.151.05
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.470.400.510.140.340.05-0.72-0.98-1.30-1.16-1.300.05
Free Cash Flow / Operating Cash Flow Ratio
0.960.860.950.890.920.791.011.021.081.221.040.92
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A1.23-16.65-29.32N/A-51.68-4.221.23
Short Term Coverage Ratio
N/AN/AN/AN/AN/A1.66-16.65-29.32N/A-51.68-30.731.66
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A